levamlodipine 2.5 MG Oral Tablet
- RxCUI
- 2377367
- RxNorm name
- levamlodipine 2.5 MG Oral Tablet
- Display name
- levamlodipine 2.5 MG Oral Tablet
- Full name
- levamlodipine 2.5 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Conjupri | LEVAMLODIPINE | CSPC Ouyi Pharmaceutical Co. Ltd | c3cca66e-348a-43e8-8f96-e995104dae3d | 2024-12-11 | Warnings, Adverse reactions | 2377367 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c3cca66e-348a-43e8-8f96-e995104dae3d | levamlodipine 2.5 MG Oral Tablet | SCD | 6 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20241211 |
| c3cca66e-348a-43e8-8f96-e995104dae3d | levamlodipine 2.5 MG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20241211 |
| c3cca66e-348a-43e8-8f96-e995104dae3d | levamlodipine 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet | SY | 6 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20241211 |
| f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4 | levamlodipine 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet | SY | 2 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20220503 |
| f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4 | levamlodipine 2.5 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20220503 |
| f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4 | levamlodipine 2.5 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use CONJUPRI ® safely and effectively. See full prescribing information for CONJUPRI ® . CONJUPRI ® (levamlodipine) tablets, for oral use. Initial U.S. Approval: 2019 | 20220503 |
| 664ea032-2dd4-41ef-8506-c453cba57144 | levamlodipine 2.5 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use LEVAMLODIPINE TABLETS safely and effectively. See full prescribing information for LEVAMLODIPINE TABLETS. LEVAMLODIPINE TABLETS, for oral use. Initial U.S. Approval: 2019 | 20211118 |
| 664ea032-2dd4-41ef-8506-c453cba57144 | levamlodipine 2.5 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use LEVAMLODIPINE TABLETS safely and effectively. See full prescribing information for LEVAMLODIPINE TABLETS. LEVAMLODIPINE TABLETS, for oral use. Initial U.S. Approval: 2019 | 20211118 |
| 664ea032-2dd4-41ef-8506-c453cba57144 | levamlodipine 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet | SY | 1 | These highlights do not include all the information needed to use LEVAMLODIPINE TABLETS safely and effectively. See full prescribing information for LEVAMLODIPINE TABLETS. LEVAMLODIPINE TABLETS, for oral use. Initial U.S. Approval: 2019 | 20211118 |